Research at the Lady Davis Institute

Although exercise is recognized as being good for cancer patients, hematologist Dr. Nathalie Johnson is taking a closer look at how it helps those with lymphoma.

Dr. Susan Kahn of the JGH Centre of Excellence in Thrombosis and Anticoagulation Care is calling for better training to prevent misdiagnosis of pulmonary embolism.

A global study, in which the LDI participated, has identified a specific gene variant that protects against severe infection by COVID-19.

As the new Director of the Lady Davis Institute, Dr. Stephen Robbins hopes to see the LDI gain even more global prominence.

t isn’t surprising that a neurologist would be interested in the root of that most fundamental element of humankind, consciousness. What is surprising is that Dr. Hyman Schipper has built a theory of consciousness based on the confluence of ancient Jewish mysticism and modern physics. “Consciousness is this fiendishly elusive …

The JGH is playing a key role in Canada’s largest biobank, which collects and stores samples of COVID-19 to help researchers better understand and fight the virus.

Dr. Stephen Robbins, new Director of the Lady Davis Institute, and Dr. Donna Senger, of the LDI’s Cancer Axis, have received up to $6.7 million in federal support for a drug candidate that could bring relief to hospitalized patients with a severe case of COVID-19.

Dr. Laurence Kirmayer, of the Institute of Community and Family Psychiatry, has received major awards from the American Family Therapy Academy and the American Psychiatric Association.

Dr. William Foulkes, an expert in cancer genetics and a senior investigator at the Lady Davis Institute, has received the 2020 Wilder Penfield Prize for his research.

Dr. Stephen Robbins has been appointed Director of the Lady Davis Institute, effective January 2021.